GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Other Current Payables

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Other Current Payables : $0.01 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Other Current Payables?

Telomir Pharmaceuticals's Other Current Payables for the quarter that ended in Mar. 2024 was $0.01 Mil.

Telomir Pharmaceuticals's quarterly Other Current Payables declined from Sep. 2023 ($1.29 Mil) to Dec. 2023 ($0.53 Mil) and declined from Dec. 2023 ($0.53 Mil) to Mar. 2024 ($0.01 Mil).

Telomir Pharmaceuticals's annual Other Current Payables increased from Dec. 2021 ($0.12 Mil) to Dec. 2022 ($0.58 Mil) but then declined from Dec. 2022 ($0.58 Mil) to Dec. 2023 ($0.53 Mil).


Telomir Pharmaceuticals Other Current Payables Historical Data

The historical data trend for Telomir Pharmaceuticals's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Other Current Payables Chart

Telomir Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23
Other Current Payables
0.12 0.58 0.53

Telomir Pharmaceuticals Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial Premium Member Only - 0.70 1.29 0.53 0.01

Telomir Pharmaceuticals Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Telomir Pharmaceuticals Other Current Payables Related Terms

Thank you for viewing the detailed overview of Telomir Pharmaceuticals's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Headlines